The multiparticulate drug product concept covering micropellets, pellets, and mini-tablets is presented as a highly feasible approach to present convenient and patient friendly medication for the geriatric population. Improved swallowability and optimized administration regimen going along with defined drug dosage are achievable. Extemporaneous preparation of medicines from standard medication can be avoided going along with improved patient safety. With one multiparticulate pellet, micropellet, or mini-tablet bulk formulation a broad range of final drug products is presentable applying well-established manufacturing technologies at viable cost.
CITATION STYLE
Pöllinger, N. (2016). Drug product development for older adults—Multiparticulate formulations. AAPS Advances in the Pharmaceutical Sciences Series, 26, 247–278. https://doi.org/10.1007/978-3-319-43099-7_16
Mendeley helps you to discover research relevant for your work.